November 27, 2024 5:08 PM
Failure of AstraZeneca’s opioid drug trial a major blow for addiction medications: report
The failure of AstraZeneca’s AZD4041 drug trial to combat opioid use disorder (OUD) highlights the challenges in developing non-opioid medications for addiction and withdrawal, according to a report on Wednesday. OUD is a chronic neurological diso...
